Skip to main content
Premium Trial:

Request an Annual Quote

Tripos Shares Up 21 Percent on News It Will Sell Informatics Business

NEW YORK (GenomeWeb News) — Shares in Tripos were up 21 percent, or $.13, at $.74 in mid-afternoon trading after the company said it has found a buyer for its Discovery Informatics business.
 
As GenomeWeb News reported this morning, Tripos said it will sell the division to Venture for $26.5 million in cash and it said it expects to distribute between $6 million and $12 million to its shareholders when the sale closes.
 
The company stated last week it is looking to sell its Discovery Research business as well.
The Scan

Test of the China Initiative

According to Science, the upcoming trial of Harvard University chemist Charles Lieber will test the US China Initiative.

Collaborative Approach

A virologist who spotted the Omicron variant of SARS-CoV-2 tells the Associated Press that its detection was aided by scientific sharing.

Genes of a Guide Dog

Wired reports on a study aimed at uncovering genes involved in being a successful guide dog.

PLOS Papers on RNAs in Metastatic Prostate Cancer, Ebola Field Lab, Embryonic RNA Editing

In PLOS this week: circRNA-mediated ceRNA network points to prostate cancer biomarkers, Ebola testing at frontline field laboratory, and more.